Skip to main content
Menu
Current research funding in the Division of Bioengineering
£14,195,068

Division of Bioengineering

Research Projects

The following are current externally funded research projects taking place within the Division of Bioengineering at Queen Mary University of London. (The funding values represents the QMUL portion in multi centre grants)

British Heart Foundation – 4 year Doctoral Training Programme


Principal Investigator: Amrita Ahluwalia
Co-investigator(s): David LEE
Funding source: British Heart Foundation
Start: 01-09-2017  /  End: 31-08-2024
Amount: £2,300,000

Led by Professors Amrita Ahluwalia and Tim Warner and involving 23 named researchers, the BHF DTP Programme provides cohort training leading to a PhD in cardiovascular research.

Tomo-SAXS: Imaging full-field molecular-to-macroscale biophysics of fibrous tissues


Principal Investigator: Himadri GUPTA
Funding source: EPSRC Engineering and Physical Sciences Research Council
Start: 01-01-2021  /  End: 30-06-2024
Amount: £451,556

KTP with Lucideon:  Cell testing to assist development of novel biomaterials
KTP with Lucideon: Cell testing to assist development of novel biomaterials


Principal Investigator: Karin HING
Co-investigator(s): Simon RAWLINSON
Funding source: Innovate UK
Start: 17-02-2021  /  End: 17-02-2024
Amount: £249,854

The aim of this programme is to transfer and embed knowledge of in vitro cell testing from QMUL to Lucideon to enable them to offer clients integrated physico-chemical and biological characterisation of materials used in medical devices & implants to improve the safety & efficacy of healthcare treatments.

The regulation of mechanosensing in healthy and atherosclerotic VSMC
The regulation of mechanosensing in healthy and atherosclerotic VSMC


Principal Investigator: Thomas ISKRATSCH
Funding source: BHF British Heart Foundation
Start: 01-12-2020  /  End: 30-11-2023
Amount: £238,021

Vascular smooth muscle cellsplay a central role in the onset and progression of many cardiovascular diseases, from atherosclerosis to vascular injury, where their migration, matrix secretion, or degradation functions are deregulated. Here we are investigating how the phenotypic switch is regulated through physical/mechanical stimuli.

A Biophysical Model of Gum Reintegration on enamel


Principal Investigator: Julien GAUTROT
Funding source: GSK GlaxoSmithKline UK Ltd
Start: 01-10-2019  /  End: 30-09-2023
Amount: £32,000

An Emulate microfluidic organ-chip
Organ-on-a-chip Centre of Excellence


Principal Investigator: Martin KNIGHT
Co-investigator(s): Hazel SCREEN and Clare THOMPSON
Funding source: Emulate Inc.
Start: 20-08-2019  /  End: 19-09-2023
Amount: £525,375

The QM-Emulate Organs-on-Chips Centre provides access to Emulate’s Organs-on-Chips technology to enable researchers to develop organ models of their design to expedite their experiments. Expert staff are on hand to support with training and use of the platform as well as pushing forward new organ-on-a-chip research projects led by Knight and Screen. The Centre also provides opportunities for collaboration with Emulate and support for commercialisation and translational impact. The centre is part of the new Centre for Predictive in vitro Models (CPM). Visit the web site to see full details of this and the new Emulate centre: https://www.cpm.qmul.ac.uk/emulate/

Diagram showing omental metastasis in high grade serous ovarian cancer
Targeting the innate immune system in high grade serous ovarian cancer


Principal Investigator: Fran Balkwill
Co-investigator(s): Olive Pearce, Daniellea Loessner, Michel Lockley, R Manchanda, Quezada S and Martin KNIGHT
Funding source: CRUK
Start: 01-10-2018  /  End: 01-09-2023
Amount: £2,028,756

This 5-year CRUK Programme Grant is led by Prof Fran Balkwill from Barts Cancer Institute with a multidisciplinary team of co-investigators including Prof Martin Knight representing cancer bioengineering and mechanobiology.

Bottom up structuring of liquids without external fields or molds.
Manufacturing of anisotropic nano and micro- particles.
Molecular Manufacturing of Macroscopic Objects - fellowship Stoyan Smoukov


Principal Investigator: Stoyan SMOUKOV
Funding source: EPSRC Engineering and Physical Sciences Research Council
Start: 01-09-2018  /  End: 31-08-2023
Amount: £1,180,624

This interdisciplinary proposal proposes a molecular basis for Manufacturing for the Future,[a1] to grow many types of particles in a nature-inspired way. It offers scalability, near-full utilization of the material, and the ability to carry out transformations at near ambient conditions. Manufacturing in nature spans the scales from intricate ...

Cells growing at the surface of oil droplets
Engineered Protein Nanosheets at Liquid-Liquid Interfaces for Stem Cell Expansion, Sorting and Tissue Engineering


Principal Investigator: Julien GAUTROT
Funding source: EU Commission - Horizon 2020
Start: 01-09-2018  /  End: 31-08-2023
Amount: £2,011,161

ProLiCell will design the biochemical and mechanical properties of extracellular matrix (ECM) protein nanosheets that can sustain the formation of adhesion protein complexes and support cell proliferation and culture on materials with very weak bulk mechanical properties (liquids).

MICA: Organ-on-a-chip models for safety testing of regenerative medicine products
MICA: Organ-on-a-chip models for safety testing of regenerative medicine products


Principal Investigator: Hazel SCREEN
Co-investigator(s): Martin KNIGHT
Funding source: MRC Medical Research Council
Start: 24-08-2020  /  End: 23-08-2023
Amount: £504,557

We are building novel organ-on-a-chip models of our musculoskeletal tissues, to learn more about disease processes and how this might be managed with regenerative medicine approaches

Proposed Emulate bone metastasis organ-chip
Organ-on-a-chip model of breast cancer bone metastases


Principal Investigator: Martin KNIGHT
Co-investigator(s): Oliver PEARCE
Funding source: CR-UK Cancer Research UK
Start: 01-12-2020  /  End: 31-05-2023
Amount: £268,711

Background A common site for invasive ductal carcinomas (IDC) metastasis is bone, affecting about 70% of patients. Once metastasis to bone has occurred the five-year survival rate drops from 99% to 29%.  How breast cancer metastasises to bone is poorly understood, partly because of the lack of appropriate models. Organ-on-a-chip technology is …

UKRMP2 Acellular / Smart Materials


Principal Investigator: Alvaro MATA
Funding source: MRC Medical Research Council
Start: 06-04-2018  /  End: 15-04-2023
Amount: £40,983

Graphene layer (Getty Image)
Graphene Flagship Core Project 3


Principal Investigator: James BUSFIELD
Co-investigator(s): Nick DUGGAN, Yang HAO, Emiliano BILOTTI, Dimitrios PAPAGEORGIOU, Wei TAN, Colin CRICK, Han ZHANG, Himadri GUPTA and Nicola PUGNO
Funding source: EU Commission - Horizon 2020
Start: 01-04-2020  /  End: 31-03-2023
Amount: £376,501

This grant will cofund the establishing of a mini-CDT with 5 PhD studentships in Graphene materials at QMUL.

Emulate Organs-on-Chips Centre Technician


Principal Investigator: Martin KNIGHT
Co-investigator(s): Hazel SCREEN and Clare THOMPSON
Funding source: Emulate Inc.
Start: 01-01-2021  /  End: 31-12-2022
Amount: £49,584

Body-worn sensor
Body-Worn Sensor for Point-of-Care Vascular Access Monitoring


Principal Investigator: Lei SU
Funding source: EPSRC Engineering and Physical Sciences Research Council
Start: 01-10-2021  /  End: 31-12-2022
Amount: £378,651

In this project, we will develop a body-worn sensor for cardiovascular monitoring, particularly to address a long-standing clinical challenge in vascular access health surveillance.

3D-photoelectrochemical imaging will be implemented using porous light-addressable semiconductors on FTO coated glass.
3D Photoelectrochemical Imaging in Porous Light-Addressable Structures


Principal Investigator: Steffi KRAUSE
Co-investigator(s): Joe BRISCOE and Thomas ISKRATSCH
Funding source: EPSRC Engineering and Physical Sciences Research Council
Start: 04-01-2021  /  End: 03-10-2022
Amount: £202,248

The project aims to develop a photoelectrochemical imaging system for mapping of electrochemical processes in three dimensions within porous electrode structures. The new technology will aid the development of novel electrode materials for energy harvesting devices and be suitable for in-situ 3D functional imaging in 3D tissue culture.

The instrument will combine two electrochemical imaging techniques which measure cell responses apically and basally.
Combined LAPS and SICM for multimodal live cell imaging


Principal Investigator: Steffi KRAUSE
Co-investigator(s): Wen WANG
Funding source: EPSRC Engineering and Physical Sciences Research Council
Start: 01-09-2018  /  End: 31-08-2022
Amount: £571,839

A novel instrument will be developed that will revolutionise the ability to monitor cellular processes and cell communication in polarised cells by simultaneously imaging cells apically and basally. This will provide information about apical cell morphology and basal ion concentrations and electrical signals such as cell surface charge and impedance.

Protein Nanosheet-Stabilised Emulsions for Next Generation Biomanufacturing


Principal Investigator: Julien GAUTROT
Funding source: EU Commission - Horizon 2020
Start: 01-03-2021  /  End: 31-08-2022
Amount: £120,000

Cardiomyocyte on PDMS nanopillar
Investigating the cardiomyocyte rigidity sensing mechanism with micro patterned surfaces and nanopil


Principal Investigator: Thomas ISKRATSCH
Funding source: BBSRC Biotechnology and Biological Sciences Research Council
Start: 01-02-2019  /  End: 31-07-2022
Amount: £490,545

The composition and the stiffness of the cardiac extracellular matrix change during development or in heart disease. Cardiomyocytes and their progenitors sense these changes, which decides over Cardiomyocyte fate. Our preliminary data suggested a cardiomyocyte specific rigidity sensing mechanism which we will investigate here in detail.

EPSRC Core Equipment 2020


Principal Investigator: Wen WANG
Co-investigator(s): Ketao ZHANG, Matteo PALMA and Ildar FARKHATDINOV
Funding source: EPSRC Engineering and Physical Sciences Research Council
Start: 01-11-2020  /  End: 30-04-2022
Amount: £497,496

Bench-top single optical fibre microendoscope- IAA Large grant
Bench-top single optical fibre microendoscope- IAA Large grant


Principal Investigator: Lei SU
Funding source: EPSRC IAA
Start: 10-03-2020  /  End: 31-03-2022
Amount: £40,000

This project aims to develop a benchtop single optical fibre imaging probe.

Super-Resolution Microscopy of live cells in 3D


Principal Investigator: Viji Draviam Sastry
Co-investigator(s): David LEE
Funding source: BBSRC
Start: 01-12-2020  /  End: 31-03-2022
Amount: £738,402

This project funds the acquisition of a novel super resolution microscope, OMX-FLEX, which will be used to develop a range of new techniques enabled by fast 3D Super-Resolution imaging of live-cells.

Hole found in the fetal membranes ten weeks after fetoscopic intervention. The surgeon created a hole through the fetal membranes to fix the problem with the baby's placenta. However, the hole never healed leading to premature rupture of the fetal membran
Healing the fetal membranes after iatrogenic PPROM


Principal Investigator: Tina CHOWDHURY
Co-investigator(s): Anna David, Alvaro MATA, , David Becker and Jan Deprest
Funding source: Great Ormond Street Hospital Children's Charity and Sparks Medical Charity
Start: 01-02-2018  /  End: 05-03-2022
Amount: £176,950

The integrity of the fetal membranes that surrounds the baby in the womb during pregnancy are vital for normal development. Once the fetal membranes have ruptured or are damaged, they fail to heal leaving a defect until the end of pregnancy. Bacteria may subsequently ascend from the vagina into the womb, causing infection both to the fetus and mother. This condition is called pre-term premature rupture of the foetal membrane (PPROM), and is a common cause of preterm birth. PPROM also complicates 30% of fetal surgeries that are increasingly being used to treat abnormalities in the unborn baby such as spine, diaphragmatic and placental defects. However, PPROM and subsequent preterm birth compromises the outcome of treated babies, reducing the clinical effectiveness of foetal surgery. There are no clinical solutions to improve healing of the foetal membrane after it ruptures.

primary cilia - confocal image
Drug repurposing for treatment of cilia-related pathologies


Principal Investigator: Martin KNIGHT
Co-investigator(s): Cleo Bishop and Dagan Jenkins
Funding source: Queen Mary Innovations
Start: 29-09-2020  /  End: 01-03-2022
Amount: £50,000

This project funded by Queen Mary Innovations, will identify compounds for the treatment of a rare genetic disease, Jeune Syndrome, that disrupts skeletal formation associated with dysregulation of primary cilia.

Newton International Fellowship 2019: Dynamics of microcapsules in inertial two-phase flows


Principal Investigator: Wen WANG
Co-investigator(s): Yi SUI
Funding source: Royal Society
Start: 01-03-2020  /  End: 28-02-2022
Amount: £103,316

Dynamics of microcapsules in inertial two-phase flows

Incorporating the circadian clock into organ-on-a-chip systems


Principal Investigator: David LEE
Co-investigator(s): Lei SU
Funding source: MRC/HEIF
Start: 01-04-2020  /  End: 31-01-2022
Amount: £102,000

Studies to support the development of more physiologically relevant in vitro model systems which incorporate the circadian clock.

Incorporating the circadian clock into Organ-on-a-chip (OOAC) devices


Principal Investigator: David LEE
Co-investigator(s): Hannah HEYWOOD and Lei SU
Funding source: MRC/HEIF
Start: 01-04-2020  /  End: 31-01-2022
Amount: £102,000

Studies to support the development of more physiologically relevant in vitro model systems which incorporate the circadian clock

Bioresorbable bioactive composites Kick off


Principal Investigator: Karin HING
Co-investigator(s): Emiliano BILOTTI
Funding source: Baxter Healthcare Corporation
Start: 11-01-2021  /  End: 10-01-2022
Amount: £36,993

Novel capsule based smell test for the assessment of hyposmia/anosmia


Principal Investigator: Ahmed ISMAIL
Co-investigator(s): Helena AZEVEDO
Funding source: EPSRC IAA & STFC IAA
Start: 01-12-2020  /  End: 31-12-2021
Amount: £9,000

This project is to develop a cheap, scalable and rapid smell test for the assessment of hyposmia/anosmia including COVID19 related symptom in humans. The prototype test consists of a standardized number of aromatic oils capsules fabricated by coaxial dripping and placed between adhesive strips that users crush and pull apart to release the smell.

Newton Mobility Grant-Prof B Garipcan: Directing fibre orientation in self-assembling peptide/polymer hydrogels via thermal manipulation


Principal Investigator: Helena AZEVEDO
Funding source: Royal Society
Start: 14-12-2020  /  End: 13-12-2021
Amount: £3,000

Open characterisation and modelling environment to drive innovation in advanced nano-architectured and bio-inspired hard/soft interfaces (OYSTER)


Principal Investigator: Gleb SUKHORUKOV
Funding source: EU
Start: 01-01-2199  /  End: 01-12-2021
Amount: £135,000

Major focus of the project is in surface design, controlled adhesion and development of surface characterisation techniques and their standardization. In particular, Nanoforce contribution in the project and relevant tasks are crossing other activity at SEMS what includes biofunctionalisation of surfaces to make hydrophobic surface hydrophilic and to produce thin polymeric films with micro-packaged bioactive agents. Also SEMS expertise in polymer processing will be expanded on polymer with drug coating. Further goal would be to make such a coating on various implants and stents. Developments of implants with designed mechanical properties could benefit with extra function added on it such as “micro-packaged” drug what could be used either to proliferate cell grow in case of grow factor encapsulation or, if needed, coatings antibacterial properties.

Light4Sight - Light-activated carriers for the controlled delivery of therapeutic peptides in posterior segment eye diseases


Principal Investigator: Helena AZEVEDO
Co-investigator(s): Yaqi LYU
Funding source: EU Commission - Horizon 2020
Start: 01-11-2019  /  End: 31-10-2021
Amount: £179,947

The growth of the ophthalmic drug market is primarily driven by an increasing aged population suffering from age- and lifestyle-related diseases such as macular degeneration, diabetic retinopathy, glaucoma, among others. These diseases cause moderate or complete vision loss, resulting in significant reduction in quality of life. Consequently, innovative approaches for the effective delivery of biopharmaceuticals for the treatment of chronic intraocular diseases are required. Currently, intravitreal injection of drugs is the most acceptable and effective method to treat vitreoretinal diseases. By placing the drug in the posterior eye, it evades the ocular barriers common in topical and systemic delivery, allowing higher drug doses to reach the target site. However, treatments require frequent injections to maintain adequate intraocular concentration, which are invasive, increase the risk of adverse effects and pose significant treatment burden on patients and healthcare providers. Thus, alternative ways to deliver these drugs that require less frequent administration need to be developed. Light4Sight aims to develop a novel delivery platform consisting of self-assembling nanocarriers incorporating therapeutic peptides and suspended within a light-sensitive supramolecular hydrogel. The hydrogel can be injected in the vitreous and release of nanocarriers be activated through the irradiation of visible light. This approach provides several benefits: 1) minimizes the use of repeated injections reducing treatment burden; 2) reduces burst release of the nanocarriers avoiding potential dose related toxicity; 3) on-demand release to match patient needs; 4) allows high drug loading for longterm therapy; 5) protects peptide drugs from rapid clearance in the vitreous increasing their half-life.